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A method is presented for the rapid detection and characterization
of trace amounts of peptides secreted from microorganisms, in-
cluding pheromones, virulence factors, and quorum-sensing pep-
tides. The procedure, based on targeted multistage MS, uses a
novel matrix-assisted laser desorptionionization-ion trap mass
spectrometer to overcome limitations of current MS methods
(limited dynamic range, signal suppression effects, and chemical
noise) that impair observation of low abundance peptides from
complex biological matrixes. Here, secreted peptides that are
hypothesized to be present in the supernatant, but that may not
be sufficiently abundant to be observed in single-stage mass
spectra, are subjected to multistage MS. Highly specific fragmen-
tation signatures enable unambiguous identification of the
peptides of interest and differentiation of the signals from the
background. As examples, we demonstrate the rapid (<1 min)
determination of the mating type of cells in colonies of Saccharo-
myces cerevisiae and the elucidation of autoinducing peptides
(AIPs) from supernatants of pathogenic Staphylococci. We confirm
the primary structures of the agrD encoded cyclic AIPs of Staphy-
lococcus aureus for groups I, II, and IV and provide direct evidence
that the native group-III AIP is a heptapeptide (INCDFLL). We also
show that the homologous peptide from Staphylococcus interme-
dius is a nonapeptide (RIPTSTGFF) with a lactone ring formed
through condensation of the serine side chain with the C terminus
of the peptide. This is the first demonstration of cyclization in a
staphylococcal AIP that occurs via lactone formation. These exam-
ples demonstrate the analytical power of the present procedure for
characterizing secreted peptides and its potential utility for iden-
tifying microorganisms.
Assays that provide information on specific peptides that aresecreted by living cells (e.g., toxins, pheromones, virulence
factors, and quorum-sensing peptides) can be valuable as diag-
nostic aids. For example, the presence and identity of a specific
microorganism may be inferred by detection of characteristic
secreted peptides, which may also be used to distinguish between
subtypes of a given strain. Several authors have described the use
of MS to identify microorganisms based on fingerprint masses of
protein constituents as well as secreted peptides and proteins (1).
Recently, electrospray ionization-Fourier transform tandem MS
(MSMS) of intact proteins has been applied for the character-
ization of biomarkers from Bacillus cereus T spores (2), and a
combined approach of single-stage MS and MSMS was used to
identify proteins secreted from adipocytes (3). Because these
methods rely on the initial detection by single-stage MS of intact
peptide ions from a highly complex milieu, it may be difficult to
detect trace amounts of the secreted peptides. In addition to
limitations imposed by dynamic range and signal suppression
effects, low-level signals of interest tend to disappear into the
‘‘chemical noise’’ (4–6). An approach that has been widely
applied with great success to the detection of trace compounds
in complex mixtures involves MSMS (7) by using targeted
compound analysis (reviewed in ref. 8). Here, we present a
method building on these previous approaches for the rapid,
unambiguous detection of trace amounts of peptides secreted
from microorganisms, by using multistage MS (MS2 and MS3)
analysis of crude supernatant mixtures with a novel matrix-
assisted laser desorptionionization (MALDI)-quadrupole ion
trap mass spectrometer (9). In this procedure, secreted peptide
ions that are hypothesized to be present in the supernatant, but
that are not sufficiently abundant to be observed in the regular
single-stage mass spectra, are subjected to multistage MS. Highly
specific fragmentation signatures enable unambiguous identifi-
cation of the peptides of interest and differentiation of the
signals from the background. As examples, we demonstrate the
rapid determination of the mating type of colonies of Saccha-
romyces cerevisiae and the detection and structural characteriza-
tion of autoinducing peptides (AIPs) of Staphylococcus aureus
that play a crucial role in quorum sensing and bacterial
interference.
Haploid yeast cells secrete one of two types of peptide
pheromones, i.e., mating factors a or  (10–12). Their expression
is controlled (but not encoded) by the alleles at the mating type
loci MATa or MAT. MATa cells secrete mating factor a, which
binds to a receptor on the surface of MAT cells, and MAT cells
secrete mating factor , which binds to a receptor on the surface
of MATa cells. Receptor binding of a mating factor triggers the
mating response, i.e., activation of proteins required for cell
fusion (13–15). Knowledge about the presence of a specific
mating factor is an indicator of a haploid strain, information that
is essential when designing mating experiments for genetic
studies. Current mating type assays use methods that challenge
the strain in question with tester-strains (16) or that analyze it by
PCR (17). These assays require overnight incubation (18) and,
so, are relatively slow (16, 19). Here, we demonstrate a rapid
method for determining the mating type in yeast.
Virulent S. aureus is an invasive pathogen that can infect
almost any human tissue. It has the potential to provoke several
forms of human disease, including food poisoning (20), skin
infections (21), endocarditis (22), and toxic shock syndrome (23).
Secreted proteins like the Staphylococcal enterotoxins belong to
a family of so-called superantigens that share the ability to trigger
excessive and aberrant activation of T cells manifested in various
symptoms from atopic dermatitis (24) to toxic shock syndromes
(23). Cell density-dependent peptide quorum sensing (25–28)
controls the secretion of these toxins, as well as a variety of other
virulence factors and surface proteins. The agr locus of S. aureus
(and the staphylococci in general) encodes the components agrB,
D, C, A, and rnaIII for such a peptide quorum-sensing system
(29). AgrB is presumed to process the propeptide precursor
AgrD to form the mature autoinducing peptides (AIPs) (30),
which are characterized by a thiolactone structure comprised of
a pentapeptide ring formed through condensation of the sulf-
hydryl group of a cysteine with the -carboxyl group of the
C-terminal amino acid. These lariat-like structures are called
autoinducing peptides because they stimulate gene expression of
several exported proteins as well themselves when they bind to
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the receptor-histidine kinase, AgrC (30, 31). The agr locus is
hypervariable leading to variations in agrD, B, and C that classify
S. aureus into four different agr groups (32) [and 20 other
putative agr groups in other staphylococcal species (33)]. AIPs
from one group usually cross-inhibit virulence specific gene
expression in S. aureus strains from a different group, and
supernatants of other staphylococcal strains usually inhibit
activation in S. aureus (34). This form of bacterial interference
(34, 35) is thought to be of clinical relevance in infection and
colonization. Thus, a rapid and reliable method to detect and
distinguish between different staphylococcal strains based on
which AIPs they secrete is potentially of great diagnostic utility.
Materials and Methods
Strains, Media, and Culture Conditions. W303 MATa, MAT, and
2N genetic background: ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100; YW046 MATa and MAT with genetic back-
ground: ura35 leu2-3,112 his3 pra1-1 prb1-1 prc1-1 cps1-3 both
from M. P. Rout (The Rockefeller University, New York);
BY4741 MATa with his31 leu20 met150 ura30 (ResGen,
Invitrogen); and crosses thereof with the first two strains. The
yeast strains where grown on YPD plates (1% yeast extract, 2%
peptone, 2% Bacto agar, and 2% D-glucose) at 30°C.
S. aureus strains used were: RN6734 (group-I AIP), RN6607
(group-II AIP), RN8465 (group-III AIP), and RN4850 (group-
IV AIP) (36). The S. intermedius strain RN9423 was kindly
provided by G. Lina (Faculte´ de Me´decine Laennec, Lyon
Cedex, France).
Preparation of AIP-Containing Supernatants. S. aureus strains were
grown in CYGP broth (10 gliter casamino acids10 gliter yeast
extract5 gliter glucose5.9 gliter NaCl60 mM -glycero-
phosphate; ref. 37) with shaking at 37°C for 9 h starting with an
inoculum of 1.5  107 cells per ml in 5 ml of broth. Cells were
removed by centrifugation at 4°C, and the supernatant was
filtered (0.22-m filter, Gelman).
Synthetic Peptides. The synthetic AIPs used in this study have
been described (38, 39). Mf and Mfa were both purchased from
Sigma.
MS. The MALDI-quadrupole ion trap was constructed from a
Thermo Finnigan LCQ Deca XP (San Jose, CA) as described for
the earlier LCQ version (9). Short ion injection times (typically
0.3–5.0 ms) were used for single-stage MS experiments to
prevent overfilling effects. MSMS and MS3 experiments were
performed at longer injection cycles (200–400 ms) by using
empirically optimized instrument specific parameters (isolation
width: 2.0 Da, normalized collision energy: 30% for yeast Mfs,
and 35% for AIPs, activation Q: 0.240, activation time: 300 ms).
Spectral acquisition times varied from 30 s to 1 min to achieve
acceptable signal:noise ratios.
Sample Preparation for MS. A needle tip amount of a yeast colony
(1–3 mg of the strains listed above) was transferred into 5 l of
half-saturated solution of 2,5-dihydroxy benzoic acid in 60%
methanol0.1% trif luoroacetic acid. After vortexing the sample,
cells were spun down by using a tabletop centrifuge. Up to 2.5
l of the supernatant was transferred onto the MALDI compact
disk (CD)-sample plate (9) and dried. Note: When screening for
Mf-producing cells only, stronger ion intensities were obtained
when the cells were suspended in 0.1% trif luoroacetic acid
lacking the organic solvent. In this case, saturated 2,5-dihydroxy
benzoic acid matrix solution was added after deposition of the
sample on the CD.
Approximately 0.5 ml of Staphylococcal culture supernatant
was lyophilized and resuspended in 100 l of 1% trif luoroacetic
acid to which was added 5 l of a suspension of hydrophobic
Poros 20 R2 beads (PerSeptive Biosystems, Framingham, MA)
in 10-fold bed volume of 2% formic acid. Using a 1-ml disposable
syringe and a self-made adapter piece (cut from a P200 pipette
tip) a portion or the entire sample was squirted through a ZipTip
microcolumn (Millipore) that also served as a frit for the Poros
material. The column-bound material was washed with 20 l of
0.1% trif luoroacetic acid before eluting it directly onto the
MALDI CD-plate by using 2.5 l of half-saturated 2,5-dihydroxy
benzoic acid solution (see above). Synthetic peptides were simply
spotted onto the MALDI CD-plate in 1-l volumes of 1 nM
solutions (or a dilution series) to which 1 l of matrix solution
were added subsequently.
Results
Hypothesis-Driven MSMS Analysis of Yeast Mating Factors (Mfs). The
left spectra in Fig. 1 show partial MALDI mass spectra of the
extracts obtained by placing a small quantity of each of the three
cell types in the MALDI matrix solution. The mass spectra
encompass the region mz 1,550–1,750, where we expect to
observe the Mf peptides. In no case do we observe the Mf
peptides in these single-stage mass spectra, so that it is not
possible to judge whether they are present or not. Indeed, the
spectra are highly congested, with just a few peptide ion peaks
apparent over the background. These more intense peptide ions,
although not identified, are not characteristic of the different
mating types because they appear in all three spectra.
In the hypothesis-driven MSMS experiment, the ion trap is
set to eject all ions except those that correspond to the theoret-
ical mz values of the Mfs. In this way, specific ions that are
hypothesized to be present are isolated and subjected to MSMS
analysis (Fig. 1). Fig. 2 shows MSMS analysis of synthetic Mfa
and Mf, where as expected the fragmentation is highly char-
acteristic of each peptide. Specifically, the most intense ions
correspond to the described preferred cleavages of singly
charged ions in the ion trap mass spectrometer, i.e., on the
C-terminal side of Asp and N-terminal side of Pro residues (40,
41). These intense fragment-ion signals define MSMS signa-
tures, which unambiguously identify the mating factors and
distinguish their ions from background ions at the same mass
(Fig. 1). Thus, crude extracts from MAT cells produce a
diagnostic MSMS spectrum when parent ions are selected at
mz 1,683.9, the calculated mz of Mf (Fig. 1 Top, right
spectrum), but no fragmentation characteristic of Mfs are ob-
served when parent ions are selected at mz 1,629.9 or 1,643.9,
the calculated mzs of Mfa (42) and its variant (43) Mfa (Fig.
1 Top, center two spectra). In the same way, MSMS with
samples of MATa cells yield diagnostic spectra when parent ions
are selected at mz 1,629.9 and 1,643.9, corresponding respec-
tively to the calculated masses of Mfa and Mfa (ref. 44; Fig. 1
Middle, two center spectra). In contrast to our observations with
haploid cells, no MSMS fragmentation characteristic of the
mating factors is obtained from diploid cells (MATa, Fig. 1
Bottom). Thus, by simply performing MSMS analysis on the
three hypothetically present Mfs, we can quickly determine
which Mf is present in the colony of interest. Signal intensities for
the Mfa and a were observed at comparable levels, which may
reflect equal expression levels of both encoding genes, MFA1
and MFA2 as reported (45). Similarly, there exists a variant
counterpart of the MF1 gene termed MF2, which encodes two
copies of Mf, one of which, Mf, varies by two amino acid
residues (Q5N and K7R) (46) [note that MF1 encodes four
identical copies of Mf (47)]. In contrast to the similar expres-
sion levels of MFA1 and MFA2, the MF2 gene does not
contribute significantly to pheromone production (48). Accord-
ingly, Mf was not detected by the present method.
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Hypothesis-Driven n-Stage MS (MSn) Analysis of Staphylococcal AIPs.
Despite concentrating and desalting the culture supernatants of
Staphylococcus aureus, it was not generally possible to decide on
the presence or absence of AIPs based on the single stage MS
spectra (Fig. 3 Top Left of I, II, III, and IV). Indeed, it proved
necessary to perform both double-stage (MSMS) and triple-
stage (MS3) experiments on synthetic AIPs to assess the most
intense fragment-ions that should be expected when analyzing
the naturally occurring AIPs from supernatants. For example,
the fragmentation of synthetic group-I AIP ions yields an intense
y6 ion peak at mz 711.5 and less intense y5 and y7 ion peaks at
mz 610.6 and 798.5, respectively (Fig. 3I). However, only the
intense y6 ion can be distinguished from the background noise in
the MSMS spectrum of natural group-I AIP supernatants.
Indeed, because of residual background in the MSMS spec-
trum, it proved necessary to perform a triple-stage MS experi-
ment (MS3) to test whether the peak at mz 711.5 from the
MSMS experiment can be attributed with high confidence to
AIP-I. The MS3 experiment with the supernatant sample of
group-I-AIP reveals essentially the same fragmentation pattern
as that obtained with the corresponding synthetic peptide. In
general, MSMS fragmentation of groups I, III, and IV AIPs
lead to fragment ions that retain the cyclic component of the
intact peptides. Because two cleavages are necessary to obtain
observable fragments from a ring, such fragment ions are first
detected in the MS3 experiments (Fig. 3).
A deviation from this scheme is observed for the group-II
AIP. This peptide is predominantly desorbed as the singly
natriated ion (MNa) rather than the more commonly ob-
Fig. 1. Hypothesis-driven multistage MS screen for yeast-mating factors. MALDI-ion trap mass spectra obtained from samples of three different S. cerevisiae
cell types: haploid MAT, haploid MATa, and diploid MATa (no mating type). Mfs are not detected by single stage MS (left spectra). MSMS experiments with
ions selected at hypothetical mz values (red arrows) reveal the presence of Mfs (red checkmarks). Only the most intense fragments are clearly seen above the
noise (compare with Fig. 2 for other fragment ions). Mf is only detected from MAT cells (Top, right spectrum). Characteristic fragments for Mfa and variant
Mfa are only obtained with MATa cells (Middle, two center spectra), and no Mfs are detected with diploid cells (Bottom, blue crosses). Aside from broadly
distributed noise, which is more intense close to the parent masses than in the lower mass range of a spectrum, some discrete peaks are designated as artifacts,
i.e., the peaks at parent mass –18, and –136.6 (marked with *). Such signals are attributed to dissociated clusters of the MALDI matrix (4). The ordinate shows
relative intensities.
Fig. 2. MALDI-ion trap MSMS spectra of synthetic yeast Mfa and Mf.
Assignment of sequence-specific MSMS signatures is indicated by fragmen-
tograms underneath [red bars indicate b ion (53) intensities and blue bars
those of y ions (53)]. The synthetic variants, Mf and Mfa, were not available
for this study (see Fig. 1 for natural Mfa).









served protonated form (MH) (Fig. 3II, synthetic), even
though the sample is prepared at low pH. Loss of phenylalanine
in the MSMS experiment indicates dissociation of the ring (Fig.
3II, ion peak at mz 754.5), which is not observed when
fragmenting the protonated synthetic peptide (data not shown).
In this case, the polar serine residues in the ring appear to chelate
the sodium cation, thus altering the fragmentation behavior.
When we assumed that the hypothetical parent ion mass of the
group-II AIP was natriated, we observed identical MSMS and
MS3 fragment ions from the peptide presumed to be present
in the culture supernatant as from the synthetic group-II AIP
(Fig. 3II).
In all these examples, only the most intense MSMS peaks can
be used with confidence to verify the presence of AIP peptides
in the supernatants; hence, only their mzs were chosen for the
MS3 experiments. The MS3 experiment was particularly neces-
sary to unambiguously verify the presence of the natural group-
III AIP because its diagnostic y5 fragment is of relatively low
intensity (Fig. 3III, natural). Moreover, in the original descrip-
tion of the AIP structures, the mature group-III AIP was
assumed to be an octapeptide (34). However, when we tested for
the presence of the peptide by using the published sequence and
calculated mass, we did not find it. Consequently, we tested a
number of other possibilities until we determined the correct
structure. In this case, it proved necessary to test 28 different
hypotheses derived from the precursor sequence, taking into
account the different possible processing sites, the possible
presence of a linear or a cyclized structure, and the possibility of
Fig. 3. Hypothesis-driven MSn analysis of groups I–IV AIPs from S. aureus culture supernatants (natural) and comparison with MSn spectra of synthetic AIPs.
Only the most abundant fragmentation pathways of these lariat-like peptides are indicated. Note that MSMS and MS3 experiments for the group-II AIP were
performed on the more abundant natriated ions (MNa); all other spectra are those of protonated ions and their fragments. The tip of the beige background
underlying the MSMS spectra points to the parent ion. MS3 spectra are marked in blue for parental y ions and in purple when derived from parental b ions.
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preference for ionization by sodium cation (as it occurred for the
group II autoinducing peptide) vs. protonation. This entire
experiment was accomplished on a single MALDI sample in
15 min, with plenty of sample remaining should it have proved
necessary to test more hypotheses. Our analysis indicated that
the group-III AIP is a heptapeptide and not an octapeptide, as
previously assumed (34). This observation corresponds well to
recent findings, which demonstrate that only the synthetic hep-
tapeptide, and not the octapeptide or nonapeptide, activates agr
group-III cells (39).
The Cyclic AIP of Staphylococcus intermedius Is a Lactone. Fivefold
concentrated, desalted culture supernatant of S. intermedius gave a
clearly discernable signal at mz 1,007.8 in the single-stage MS
mode (Fig. 4). It would be possible to assign this signal to the AIP
of S. intermedius if one assumes that the AIP is a nonapeptide and
that cyclization is accomplished via a lactone bond rather than the
previously discussed thiolactone (because the S. intermedius AIP
contains a serine instead of a conserved cysteine residue at the
corresponding position in all other AIPs examined). To test these
hypotheses, multistage MS experiments were performed on the
ions at mz 1,007.8 and on fragments thereof (Fig. 4). Three
fragments (y8, y7, and b4) were obtained in the MSMS experiment.
None of these fragmentations occurs within the presumed cyclic
part of the peptide, a characteristic that corresponds to observations
made when studying MSMS fragmentation of protonated S.
aureus AIPs. The b4 ion at mz 468.3 results from fragmentation of
the peptide bond C-terminal to the threonine, which is the first
residue outside the ring. The identity of the b4 ion was verified by
a MS3 experiment that yielded b2 ions (Fig. 4). The y7 ion at mz
738.5, observed in the MSMS experiment, results from a preferred
fragmentation of the peptide bond on the N-terminal side of proline
that is also responsible for generating b2 ions in the MS3 experiment
on b4 ions. The y7 ion comprises the cyclic portion of the peptide,
making it 18 Da lighter than its theoretical linear counterpart.
Subsequent fragmentation of the y7 ion in an MS3 experiment leads
to y5 and y6 ions (mzs 540.3 and 641.2) that also originate from
bond dissociations outside the ring. These spectra provide strong
evidence that the S. intermedius AIP is indeed a nonapeptide with
a cyclized portion comprised of a lactone.
Sensitivity. Tests performed with synthetic factor  diluted into
pure solutions of the MALDI matrix yielded informative
MSMS spectra (comparable to those shown in Fig. 2) at the 1
fmol level, i.e., at 1 nM concentration. The sensitivity was
reduced 30-fold when the same peptide was introduced into
suspensions of diploid yeast cells. Biologic activity assays for the
AIPs suggest concentrations on the order of 30 nM in superna-
tants of late logarithmic cultures (109 cells per ml) (36, 39). AIP
concentrations from a S. epidermidis strain were also reported to
be in the same range (49).
Discussion
The present method is based on the ability of MALDI-ion trap
MS to separate specified peptide ions from a complex and noisy
mixture and to convert these selected peptide ions into a few
informative fragment species with low noise background. Res-
onant excitation within the ion trap provides an efficient method
to cleave peptide bonds at preferred positions, leading to rela-
tively simple fragmentation signatures with high signal-to-noise
ratios. Key to the success of the approach is the very small
fraction of the total sample that is consumed to obtain each
multistage mass spectrum. Consequently, we are able to test a
large number of different hypotheses (100) on a given sample
before it is depleted. It is of interest to compare the present
approach for testing hypotheses with alternatives that use LC-
MSMS (ref. 50 and references cited therein) where the number
of hypotheses that can be tested is limited by the chromato-
graphic peak width and the time required to acquire an MSMS
spectrum. For example, a combination of isotope-coded affinity
tag (ICAT) methodology and online HPLC-MSMS was re-
cently used to test for the presence of a protein of interest from
a complex mixture of proteins. In this case, it was possible to test
for the presence of up to four peptides in a given LC run
(compare with100 tests by using the present method). The low
utilization and stability of MALDI samples allow us to test
hypotheses until we have exhausted many of the alternatives or
even allow us to return to the problem after weeks of reflection.
Any instrumentation with the properties outlined above should
be capable of carrying out hypothesis-driven experiments of type
described. Possibilities include Quadrupole quadrupole time-of-
f light (Qq-TOF), TOF-TOF, and Fourier transform on cyclo-
tron resonance (FT-ICR) analyzers.
The method proved extremely facile for yeast random spore
analyses as well as for tetrad analyses that require testing for diploid
contaminants. Technical problems that result from ambiguous
halos around closely spaced colonies could be readily overcome by
applying this on-the-spot mass spectrometric procedure. Although
the present hypothesis driven multistage-MS approach for assaying
mating pheromones from yeast colonies does not require any
purification, concentration, or desalting steps, we found such steps
to be useful for the analysis of Staphylococcal AIPs from liquid
culture supernatants. A fast (1 min) and simple ZipTip procedure
performed with small culture volumes (0.01–1 ml) proved ade-
quate. Hypothetical masses that form the basis for any hypothesis-
driven multistage-MS experiment have to be assessed carefully as
the example of the natriated group-II-AIP ions demonstrates. The
S. intermedius AIP is the only AIP in our study that contains a
residue with a highly basic side chain (arginine). The presence of
this arginine residue may explain why this AIP can readily be
observed in single-stage MS mode with samples prepared from
crude culture supernatants. Because the intensities of fragment ions
of these modified, nontryptic peptide ions are difficult to predict,
synthetic peptides, rather than database searches, were used to
Fig. 4. MALDI-ion trap MSn characterization of the S. intermedius AIP from
culture supernatants. MS3 spectra are marked in blue for parental y ions and
in purple when derived from parental b ions. The AIP is a nonapeptide whose
circular portion comprises a lactone.









increase the confidence level of our results. Although no synthetic
form of the S. intermedius AIP was available for analysis, the MS2
and MS3 experiments of the natural AIP (Fig. 4) unambiguously
characterize it as a nonapeptide lactone, which is the first such
peptide characterized in agr signaling. This finding has important
implications for understanding the detailed interaction of AIPs
with their receptor. It has previously been demonstrated that the
interaction of AIPs with the receptor, AgrC, is reversible and
competitive (51), but it was not determined whether or not this
interaction involved a transient covalent linkage step. In principle,
such a step is conceivable because the S. aureus AIPs contain a
reactive thioester linkage. The fact that we now have characterized
a S. intermedius AIP lactone, which has much lower reactivity than
a thioester, provides evidence against such a covalent interaction
model. The use of lactone peptides for quorum sensing was also
recently shown in the Gram-positive bacterium, Enterococcus
faecalis (52).
Conclusion
Clearly, the method presented here is not limited to the detection
of secreted peptides. It has the potential to be used for a very
broad range of applications that include detection of any protein
via its proteolytic fragments. Indeed, when the mass and frag-
mentation behavior of a specified peptide is known, hypothesis-
driven multistage MS functions in a manner analogous to
Western blotting, but with the potential for greater speed and
throughput, while eliminating the need for a specific Ab.
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